## **Core Concept**
Organophosphate poisoning (OPC) is a critical condition that requires immediate treatment. Pralidoxime is a key antidote used in conjunction with atropine to manage OPC poisoning. It works by reactivating acetylcholinesterase, the enzyme inhibited by organophosphate compounds.

## **Why the Correct Answer is Right**
The correct dose of pralidoxime in OPC poisoning, as per the National Institute of Mental Health and Neurosciences (NIMHANS) guidelines, is crucial for effective treatment. Pralidoxime is administered as an intravenous infusion. The recommended dose often cited is an initial dose of 1-2 grams (or 30 mg/kg) over 30 minutes, followed by a continuous infusion of 8-10 mg/kg/hour. However, specific guidelines like NIMHANS might have tailored recommendations.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not align with the standard dosing recommendations for pralidoxime in OPC poisoning.
- **Option B:** Similarly, this option does not match the commonly recommended doses and could be considered too low or too high based on standard protocols.
- **Option D:** This option might suggest a dose that is not consistent with guidelines or could be misleading without specific context.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that pralidoxime should be used early in the treatment of OPC poisoning for optimal benefit. Delayed administration may result in reduced efficacy. Also, remember that pralidoxime does not cross the blood-brain barrier effectively, so it might not be as effective for central effects of OPC poisoning.

## **Correct Answer:** C.